Elevated p-selectin on platelets in depression: Response to bupropion

Journal of Psychiatric Research

Volumn 34, Issue 6, 2000, Pages 397-404

  Piletz, J E ^a   Zhu, H ^a   Madakasira, S ^a   Pazzaglia, P ^b   Lindsay DeVane, C ^c   Goldman, N ^a   Halaris, A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b HCP 3C 06 ^*  (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

3 Integrin; Bupropion; CD62; Depression; Ischemic heart disease; p Selectin; Platelets

Indexed keywords

AMFEBUTAMONE; BETA3 INTEGRIN; PADGEM PROTEIN;

ADULT; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HAMILTON SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; TREMOR; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BUPROPION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION;

EID: 0034495139     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(00)00034-0     Document Type: Article

References (41)

1. Direct detection of activated platelets and platelet-derived microparticles in humans
2. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults
3. Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms
4. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders
5. Elevated platelet intracellular calcium concentration in bipolar depression
6. Platelet and lymphocyte free intracellular calcium in affective disorders
7. Biochemical effects of bupropion in depression
8. Depression is a risk factor for coronary artery disease in men: the precursors study
9. Gender, depression, and one-year prognosis after myocardial infarction
10. Social support, depression and mortality during the first year after myocardial infarction
11. Bupropion in depression
12. 2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome
13. Plasma agmatine and platelet imidazoline receptors in depression
14. Development of a rating scale for primary depression
15. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets
16. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists
17. Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age
18. Serotonin-induced platelet intracellular calcium mobilization in depressed patients
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease
21. Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and in healthy controls
22. Effects of sertraline treatment of depression on platelet activation in an open-label study: implications for coronary disease
23. Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets
24. Exaggerated platelet reactivity in major depression
25. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease
26. Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants; seven case reports and review of the literature
27. Further studies on platelet serotonin transporter binding in depression
28. Yohimbine and clonidine recognize different states of adrenergic receptors on human platelets
29. 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients
30. 1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder
31. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
32. Platelets as models: use and limitations
33. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up
34. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
35. Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression
36. Role of platelet activation and fibrin formation in thrombogenesis
37. Pressel S, Schron E. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the elderly)
38. A systematic review of the mortality of depression
39. 2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets
40. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients